Daewoong Group Will Launch a New Scholarship Program in Indonesia

VIVA English – Daewoong Group initiates the Daewoong Young Creator campaign, by forming a group of student journalists in Indonesia.

It is a student ambassador program developed as an extension of the Daewoong Social Impactor campaign, conducted with Indonesian students since 2021.

This year program is further developed in the format of a student journalist group covering news about the local Daewoong Group, which is around 20 years old, in Indonesia, as well as the career stories of company employees at the headquarters in Seoul.

Through a document selection process and online interviews, a total of 20 students will be chosen as Daewoong Young Creators.

They will provide training on planning and producing content for new media for approximately six months, from May to October, with monthly missions that offer practical experience in content production.

Specifically, Daewoong Group will prepare content missions related to career development and the future of students, hoping to attract the interest of selected students to join this campaign.

The selected team of 20 journalists will receive a scholarship covering the cost of one semester's tuition. Additionally, an initial package consisting of items to assist in reporting and completing field tasks will also be provided to them.

This initial package includes an introduction brochure about Daewoong Group, a CEO's greeting card, a Bluetooth microphone, a camera tripod, a business card wallet, and other items that will enhance understanding of Daewoong Group and support students starting their journalistic activities.

Seng-ho Jeon, CEO of Daewoong Pharmaceutical, stated, "Daewoong continues to grow together with Indonesian global talents with the aim of improving the quality of life for the Indonesian people and enhancing the competitiveness of the biotechnology pharmaceutical industry."

On the other hand, the company is promoting business diversification such as local production, technology transfer, and the establishment of research centers as strategies to become a leading pharmaceutical company in Indonesia based on a comprehensive local strategy.